Home LiteratureArticle Details
PMID: 6815213 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Electron microscopy of human factor VIII/Von Willebrand glycoprotein: effect of reducing reagents on structure and function.

The Journal of cell biology ·Vol. 95 ·No. 2 Pt 1 ·1982-11-00 ·Pages 632-40

Ohmori K, Fretto LJ, Harrison RL, Switzer ME, Erickson HP, McKee PA

Abstract

The structure of native and progressively reduced human factor VIII/von Willebrand factor (FVIII/vWF) was examined by electron microscopy and SDS gel electrophoresis and then correlated with its biological activities. Highly resolved electron micrographs of well-spaced, rotary-shadowed FVIII/vWF molecules showed their structure to consist of a very flexible filament that contains irregularly spaced small nodules. Filaments ranged from 50 to 1,150 nm with a mean length of 478 nm and lacked fixed, large globular domains as seen in fibrinogen and IgM. A population of multimeric FVIII/vWF species ranging in molecular weight from 1 to 5 million daltons and differing in size alternately by one and two subunits was observed on SDS-2% polyacrylamide-0.5% agarose gel electrophoresis. With progressive reduction of disulfide bonds by dithiothreitol (DTT), the electron microscopic size of FVIII/vWF decreased in parallel with increased electrophoretic mobility on SDS-agarose gels; between 0.1 and 0.5 mM DTT its structure changed from predominantly fibrillar species to large nodular forms. A 50% loss of vWF specific activity and FVIII procoagulant activity occurred at 0.4 mM DTT and 1 mM DTT, respectively, corresponding to the reduction of 4 and 12 disulfide bonds of the 62 disulfides per 200,000-dalton subunit. We conclude that reduction of a few critical disulfide bonds results in a major structural change by electron microscopy and a concomitant loss of approximately 50% of the vWF function.

MeSH Terms
Alkylation Blood Coagulation Factors/physiology Blood Platelets/metabolism Dithiothreitol/pharmacology Factor VIII/physiology Humans Macromolecular Substances Mercaptoethanol/pharmacology Microscopy, Electron Molecular Weight Platelet Aggregation Protein Conformation Ristocetin/pharmacology Structure-Activity Relationship von Willebrand Factor/physiology
Chemicals
Blood Coagulation Factors Macromolecular Substances von Willebrand Factor Ristocetin Mercaptoethanol Factor VIII Dithiothreitol
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Ohmori K
Fretto L J
Harrison R L
Switzer M E
Erickson H P
McKee P A
References (46)
46 references, click to expand
  1. Molecular weight estimation and separation of ribonucleic acid by electrophoresis in agarose-acrylamide composite gels.
    Biochemistry. 1968 Feb;7(2):668-74 PMID: 4868544
  2. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.
    J Biol Chem. 1969 Aug 25;244(16):4406-12 PMID: 5806584
  3. Methods for the production of clinically effective intermediate- and high-purity factor-VIII concentrates.
    Br J Haematol. 1971 Jul;21(1):1-20 PMID: 5559480
  4. Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin.
    J Biol Chem. 1973 Feb 25;248(4):1395-407 PMID: 4405643
  5. Isolation and characterization of human Factor VIII (antihemophilic factor).
    J Biol Chem. 1973 Jun 10;248(11):3946-55 PMID: 4708094
  6. The subunit structure of normal and hemophilic factor VIII.
    J Clin Invest. 1973 Sep;52(9):2198-210 PMID: 4199414
  7. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    J Clin Invest. 1973 Nov;52(11):2697-707 PMID: 4201262
  8. Dissociation of Factor VIII-related antigen into subunits.
    Nature. 1975 Jan 3;253(5486):55-6 PMID: 1110751
  9. Factor VIII.
    Ann N Y Acad Sci. 1975 Jan 20;240:70-3 PMID: 1053889
  10. Molecular structural studies of human factor VIII.
    Ann N Y Acad Sci. 1975 Jan 20;240:8-33 PMID: 122889
  11. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.
    J Clin Invest. 1976 Apr;57(4):925-37 PMID: 1084890
  12. Von Willebrand's disease.
    Prog Hemost Thromb. 1976;3:231-87 PMID: 781732
  13. The dissociation of factor VIII by reducing agents, high salt concentration and affinity chromatography.
    Thromb Haemost. 1976 Feb 29;35(1):191-201 PMID: 989186
  14. Selective destruction of the platelet aggregation component in bovine factor VIII preparations by reduction.
    Thromb Res. 1976 Jun;8(6):777-83 PMID: 960053
  15. Studies of von Willebrand factor: effects of different kinds of carbohydrate oxidases, SH-inhibitors and some other chemical reagents.
    Br J Haematol. 1977 Jun;36(2):259-70 PMID: 301402
  16. Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein.
    J Biol Chem. 1977 Aug 10;252(15):5538-46 PMID: 301877
  17. Human factor VIII: morphometric analysis of purified material in solution.
    Science. 1977 Dec 2;198(4320):932-4 PMID: 303809
  18. Porcine Willebrand factor: a population of multimers.
    J Lab Clin Med. 1978 Feb;91(2):307-20 PMID: 413873
  19. Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor.
    J Clin Invest. 1978 Sep;62(3):702-9 PMID: 308512
  20. The effect of reducing agents on factor VIII and other coagulation factors.
    Thromb Res. 1978 Jun;12(6):1177-94 PMID: 358483
  21. Carbohydrate on human factor VIII/von Willebrand factor. Impairment of function by removal of specific galactose residues.
    J Biol Chem. 1978 Oct 25;253(20):7202-6 PMID: 100492
  22. Comparison of factor VIII-related von Willebrand factor proteins prepared from human cryoprecipitate and factor VIII concentrate.
    Blood. 1979 Jun;53(6):1095-105 PMID: 312667
  23. Studies on factor VIII-related protein. I. Ultrastructural and electrophoretic heterogeneity of human factor VIII-related protein.
    Biochim Biophys Acta. 1979 May 23;578(1):155-63 PMID: 313218
  24. Studies on factor VIII-related protein. II. Estimation of molecular size differences between factor VIII oligomers.
    Biochim Biophys Acta. 1979 May 23;578(1):164-74 PMID: 454664
  25. Molecular size distribution of factor VIII in native plasma.
    Thromb Res. 1979;14(4-5):589-98 PMID: 483257
  26. The molecular structure of human erythrocyte spectrin. Biophysical and electron microscopic studies.
    J Mol Biol. 1979 Jun 25;131(2):303-29 PMID: 490648
  27. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
    Proc Natl Acad Sci U S A. 1979 Oct;76(10):5317-20 PMID: 315561
  28. An improvemed assay for von Willebrand factor.
    Am J Clin Pathol. 1979 Dec;72(6):991-5 PMID: 117698
  29. Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease.
    J Lab Clin Med. 1980 Apr;95(4):590-602 PMID: 6965697
  30. Trinodular structure of fibrinogen. Confirmation by both shadowing and negative stain electron microscopy.
    J Mol Biol. 1979 Oct 25;134(2):241-9 PMID: 537064
  31. Factor VIII-related protein circulates in normal human plasma as high molecular weight multimers.
    Blood. 1980 Jun;55(6):1056-9 PMID: 6769518
  32. Rotary shadowing of extended molecules dried from glycerol.
    J Ultrastruct Res. 1980 May;71(2):95-102 PMID: 6155474
  33. Electron microsocpy of plasmic fragments of human fibrinogen as related to trinodular structure of the intact molecule.
    J Clin Invest. 1980 Jul;66(1):50-6 PMID: 7400308
  34. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    J Clin Invest. 1980 Jun;65(6):1318-25 PMID: 6773982
  35. Fibronectin.
    Prog Hemost Thromb. 1980;5:111-51 PMID: 6999530
  36. Factor VIII/von Willebrand protein. Modification of its carbohydrate causes reduced binding to platelets.
    J Biol Chem. 1980 Nov 10;255(21):10134-9 PMID: 6776109
  37. Reactions of thrombin with human factor VIII/von Willebrande factor protein.
    J Biol Chem. 1980 Nov 25;255(22):10606-11 PMID: 6776120
  38. Structural studies of the functional heterogeneity of von Willebrand protein polymers.
    Blood. 1981 Feb;57(2):313-23 PMID: 6969614
  39. The role of phospholipid and factor VIIIa in the activation of bovine factor X.
    J Biol Chem. 1981 Apr 10;256(7):3433-42 PMID: 6782101
  40. The complex multimeric composition of factor VIII/von Willebrand factor.
    Blood. 1981 Jun;57(6):1140-3 PMID: 6784794
  41. The factor VIII complex: structure and function.
    Blood. 1981 Jul;58(1):1-13 PMID: 6165414
  42. Effect of multimeric structure of the factor VIII/von Willebrand factor protein on binding to platelets.
    Blood. 1981 Aug;58(2):387-97 PMID: 6788111
  43. Observations on structure-function relationships of human antihemophilic/von Willebrand factor protein.
    Ann N Y Acad Sci. 1981;370:210-26 PMID: 6791544
  44. Shapes, domain organizations and flexibility of laminin and fibronectin, two multifunctional proteins of the extracellular matrix.
    J Mol Biol. 1981 Jul 25;150(1):97-120 PMID: 6795355
  45. Fibronectin molecule visualized in electron microscopy: a long, thin, flexible strand.
    J Cell Biol. 1981 Dec;91(3 Pt 1):673-78 PMID: 7328116
  46. Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure.
    J Lab Clin Med. 1953 Apr;41(4):637-47 PMID: 13045017
Article Info
Journal
The Journal of cell biology
Abbr.
J Cell Biol
ISSN
0021-9525
Published
1982-11-00
Pages
632-40
Language
English
Region
United States
NLM ID
0375356
PMCID
PMC2112957
Subset
IM
Grants
NHLBI NIH HHS · HL 15615 · United States
NHLBI NIH HHS · HL 23454 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com